Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation
- 1 April 2014
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 13 (2) , 338-346
Abstract
Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM) are two progressive and devastating health disorders afflicting millions of people worldwide. The probability and incidence of both have increased considerably in recent years consequent to increased longevity and population growth. Progressively more links are being continuously found between inflammation and central nervous system disorders like AD, Parkinson's disease, Huntington's disease, motor neuron disease, multiple sclerosis, stroke, traumatic brain injury and even cancers of the nervous tissue. The depth of the relationship depends on the timing and extent of anti- or pro-inflammatory gene expression. Inflammation has also been implicated in T2DM. Misfolding and fibrillization (of tissue specific and/or non-specific proteins) are features common to both AD and T2DM and are induced by as well as contribute to inflammation and stress (oxidative/ glycation). This review appraises the roles of inflammation and abnormalities in the insulin signaling system as important shared features of T2DM and AD. The capacity of anti-cholinesterases in reducing the level of certain common inflammatory markers in particular if they may provide therapeutic potential to mitigate awry mechanisms leading to AD.Keywords
This publication has 137 references indexed in Scilit:
- RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's diseaseThe FASEB Journal, 2009
- IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK ratProceedings of the National Academy of Sciences, 2009
- Association of C-reactive protein and muscle strength in the English Longitudinal Study of AgeingAGE, 2009
- GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and ParkinsonismProceedings of the National Academy of Sciences, 2009
- Inflammation, ageing and cancerMechanisms of Ageing and Development, 2009
- Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's miceJournal of Cell Biology, 2007
- Oxidative stress mediates tau-induced neurodegeneration in DrosophilaJournal of Clinical Investigation, 2007
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006
- Inhibition of Human Acetyl- and Butyrylcholinesterase by Novel Carbamates of (−)- and (+)-Tetrahydrofurobenzofuran and MethanobenzodioxepineJournal of Medicinal Chemistry, 2006
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996